Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.95B |
| 2 |
Digital Realty Trust
DLR
|
+$1.42B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.36B |
| 4 |
Canadian Natural Resources
CNQ
|
+$966M |
| 5 |
US Bancorp
USB
|
+$658M |
Top Sells
| 1 |
Apple
AAPL
|
+$2.4B |
| 2 |
Gilead Sciences
GILD
|
+$2.3B |
| 3 |
Biogen
BIIB
|
+$1.75B |
| 4 |
Goldman Sachs
GS
|
+$1.15B |
| 5 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$1.12B |
Sector Composition
| 1 | Healthcare | 21.03% |
| 2 | Technology | 12.36% |
| 3 | Industrials | 11.39% |
| 4 | Communication Services | 10.61% |
| 5 | Consumer Staples | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHK
151
DELISTED
Chesapeake Energy Corporation
CHK
| $421M | 0.14% |
107,475
+30,875
| +40% | +$121M |
|
152
Sprouts Farmers Market
SFM
$12.3B
| $421M | 0.14% |
12,375,926
+3,510,700
| +40% | +$119M |
|
153
Golar LNG
GLNG
$4.09B
| $417M | 0.14% |
11,426,771
+3,508,554
| +44% | +$128M |
|
154
Starwood Property Trust
STWD
$7.44B
| $410M | 0.14% |
17,657,000
-149,200
| -0.8% | -$3.47M |
|
155
Merck
MRK
$202B
| $406M | 0.14% |
7,496,538
| – | – |
|
156
Textron
TXT
$14.9B
| $400M | 0.14% |
9,495,209
-3,649,457
| -28% | -$154M |
|
157
Charles Schwab
SCHW
$165B
| $398M | 0.14% |
13,187,300
+2,331,300
| +21% | +$70.4M |
|
158
Domino's
DPZ
$15B
| $397M | 0.13% |
4,213,200
+682,200
| +19% | +$64.2M |
|
159
CMS Energy
CMS
$21.1B
| $396M | 0.13% |
11,394,300
| – | – |
|
160
AutoNation
AN
$8.24B
| $394M | 0.13% |
6,519,000
| – | – |
|
161
Emerson Electric
EMR
$72.2B
| $393M | 0.13% |
6,373,539
-1,399,710
| -18% | -$86.4M |
|
162
Carlisle Companies
CSL
$14.7B
| $390M | 0.13% |
4,325,214
+269,714
| +7% | +$24.3M |
|
163
Viavi Solutions
VIAV
$2.7B
| $387M | 0.13% |
49,537,406
+8,008,042
| +19% | +$62.5M |
|
|
ROC
164
DELISTED
ROCKWOOD HLDGS INC
ROC
| $386M | 0.13% |
4,897,388
| – | – |
|
|
WBA
165
DELISTED
Walgreens Boots Alliance
WBA
| $386M | 0.13% |
5,061,400
| – | – |
|
166
Autodesk
ADSK
$67.8B
| $385M | 0.13% |
6,405,000
| – | – |
|
|
NBIS
167
Nebius Group N.V. Class A Ordinary Shares
NBIS
$21.3B
| $382M | 0.13% |
21,269,000
+389,900
| +2% | +$7M |
|
168
Boston Scientific
BSX
$148B
| $381M | 0.13% |
28,778,792
-19,193,694
| -40% | -$254M |
|
169
Williams-Sonoma
WSM
$23.9B
| $380M | 0.13% |
10,052,000
-3,400,000
| -25% | -$129M |
|
|
GEVA
170
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $378M | 0.13% |
4,069,258
+6,486
| +0.2% | +$602K |
|
171
AptarGroup
ATR
$8.88B
| $377M | 0.13% |
5,641,500
-193,660
| -3% | -$12.9M |
|
|
DNY
172
DELISTED
DONNELLEY R R & SONS CO
DNY
| $369M | 0.13% |
21,963,457
+4,058,094
| +23% | +$68.2M |
|
173
Puma Biotechnology
PBYI
$231M
| $368M | 0.13% |
1,944,740
+109,240
| +6% | +$20.7M |
|
174
Revvity
RVTY
$9.91B
| $366M | 0.12% |
8,378,428
+3,401,428
| +68% | +$149M |
|
175
Public Storage
PSA
$50.2B
| $360M | 0.12% |
1,945,000
-658,500
| -25% | -$122M |
|